SDS

Lithium Ion Polymer Rechargeable Battery (MB1-1480mAh-11.4V
11.4V 1480mAh 16.87Wh )
Revision Date 31-Mar.-2017
_____________________________________________________________________________________________
_____________________________________________________________________________________________
Page 8 / 12
Carbon black
1333-86-4
> 15400 mg/kg ( Rat )
> 3 g/kg ( Rabbit )
-
Information on toxicological effects
Symptoms
Erythema (skin redness). May cause redness and tearing of the eyes. May cause blindness.
Burning.
Delayed and immediate effects as well as chronic effects from short and long-term exposure
Sensitization
No information available.
Mutagenic Effects
No information available.
Carcinogenicity
The table below indicates whether each agency has listed any ingredient as a carcinogen.
Chemical name
ACGIH
IARC
NTP
OSHA
Lithium Cobalt Oxide
(CoLiO2)
12190-79-3
A3
Group 2B
X
Carbon black
1333-86-4
A3
Group 2B
X
ACGIH (American Conference of Governmental Industrial Hygienists)
A3 - Animal Carcinogen
IARC (International Agency for Research on Cancer)
Group 2B - Possibly Carcinogenic to Humans
OSHA (Occupational Safety and Health Administration of the US Department of Labor)
X - Present
Reproductive toxicity
No information available.
STOT - single exposure
No information available.
STOT - repeated exposure
Causes damage to organs through prolonged or repeated exposure. Based on classification
criteria from the 2012 OSHA Hazard Communication Standard (29 CFR 1910.1200), this
product has been determined to cause systemic target organ toxicity from chronic or
repeated exposure. (STOT RE).
Chronic Toxicity
Contains a known or suspected carcinogen. Avoid repeated exposure. Prolonged exposure
may cause chronic effects. May cause adverse liver effects.
Target Organ Effects
Respiratory system. Eyes. Skin. Gastrointestinal tract (GI). Central Vascular System (CVS).
Lymphatic System. Liver. Lungs.
Aspiration Hazard
No information available.
Numerical measures of toxicity Product Information
The following values are calculated based on chapter 3.1 of the GHS document
ATEmix (oral)
6,399.00 mg/kg
ATEmix (dermal)
5,300.00 mg/kg (ATE)